FDA Inspection 1207942 — Reproductive Endocrine Center Sperm Physiology Lab

Reproductive Endocrine Center Sperm Physiology Lab — FEI 3005374803

The FDA completed an inspection of Reproductive Endocrine Center Sperm Physiology Lab on June 8, 2023 in Orange, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Orange, CT (United States)